Still, these results suggest that the circadian clock can regulate TMZ toxicity in GBM also in humans, and that adapting TMZ administration to the peak of BMAL1 expression in GBM cells can enhance its efficiency,60 (Fig. 1c). This evidence concerns the gene BMAL1 and glioblastoma.